The Efficacy of Oral Antiseptics Against SARS-CoV-2

• Status: Completed
• Trial end date: 2021-12-07
• Target enrollment: 0
• Participant gender: All

Summary

In a study conducted on 75 COVID-19 patients, the effect of SARS-CoV-2 on viral load was investigated as a result of the use of hypochlorous acid and povidone-iodine as an oral antiseptic.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ataturk University
• Treatments: Povidone; Povidone-Iodine

Criteria

Inclusion Criteria:

• Positive SARS-CoV-2 RT-PCR result,

• Adult hospitalized patient,

• The patient has the physical and psychological ability to follow the instructions in the study.

Exclusion Criteria:

• Patients intubated and supported by a mechanical respirator,

• Severe acute or chronic medical or psychiatric condition,

• History of significant adverse effects following use of oral hygiene products such as toothpaste and mouth rinses,

• Active uncontrolled thyroid disease,

• Developmental/cognitive disability,

• Pregnancy,

• Undergoing radioactive iodine therapy.